{"nct_id":"NCT02036502","title":"A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)","status":"TERMINATED","status_verified_date":"2021-03","start_date":"2014-02-14","start_date_type":"ACTUAL","primary_completion_date":"2020-03-19","primary_completion_date_type":"ACTUAL","completion_date":"2020-03-19","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}